<div id="readability-page-1"><div><p><span>Natco Pharma Ltd </span><span>:</span></p><ul><li>NATCO PHARMA - API UNIT IN CHENNAI RECEIVES ESTABLISHMENT INSPECTION REPORT FROM U.S. FDA</li><li>NATCO PHARMA - API UNIT IN CHENNAI RECEIVES EIR FROM U.S. FDA</li><li>NATCO PHARMA - COMPANY RECEIVED SEVEN OBSERVATIONS</li><li>NATCO PHARMA - RECEIVED EIR CLASSIFIED AS VOLUNTARY ACTION INDICATED</li></ul></div></div>

<p>Natco Pharma Ltd :NATCO PHARMA - API UNIT IN CHENNAI RECEIVES ESTABLISHMENT INSPECTION REPORT FROM U.S. FDANATCO PHARMA - API UNIT IN CHENNAI RECEIVES EIR FROM U.S. FDANATCO PHARMA - COMPANY RECEIVED SEVEN OBSERVATIONSNATCO PHARMA - RECEIVED EIR CLASSIFIED AS VOLUNTARY ACTION INDICATED</p>

Reuters

Proshares Ultra Nasdaq Biotech

iShares Biotechnology ETF

Invesco Biotechnology & Genome ETF

Ark Genomic Revolution ETF

VG Health

NervGen Pharma

iShares US Pharma

SPDR S&P Biotech

First Trust NYSE Arca Biotech Index Fd

VanEck Biotech ETF

Cocrystal Pharma

ALPS Medical Breakthrough

Health Care Select Sector SPDR

Natco Pharma Says API Unit In Chennai Receives Establishment Inspection Report From U.S. FDA